GNH USA

Europe — EMA

Macrogol Aurovitas (Macrogol 4000)

GNH USA supplies Macrogol Aurovitas (Macrogol 4000), an osmotic laxative for constipation and bowel preparation. Request a quote for global supply today.

Macrogol 4000

Request sourcing

1
Pack/s

What is Macrogol 4000?

Macrogol 4000, the active ingredient in Macrogol Aurovitas, is an osmotic laxative presented as an oral powder for solution for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic procedures such as colonoscopy.

GNH USA supplies Macrogol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards, is manufactured under GMP conditions, and its consistent purity and performance support clinical use across diverse patient populations.

What is Macrogol 4000 used for?

Macrogol Aurovitas (macrogol 4000) is an osmotic laxative used to manage conditions involving reduced bowel motility.

- Constipation: softens stool and facilitates regular bowel movements. - Chronic idiopathic constipation: provides long‑term relief of infrequent stools. - Bowel preparation for colonoscopy: clears intestinal contents before diagnostic procedures. - Fecal impaction: helps evacuate impacted stool in acute settings.

What are the side effects of Macrogol 4000?

Macrogol Aurovitas may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Nausea: mild feeling of queasiness. - Abdominal discomfort: cramping or mild pain. - Diarrhea: loose stools occurring more frequently. - Increased thirst: sensation of needing more fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal levels of sodium, potassium, or other electrolytes. - Allergic reaction: rash, itching, or angioedema. - Dehydration: excessive loss of body fluids. - Severe abdominal pain: intense or persistent pain. - Rectal bleeding: presence of blood in stool. - Anaphylaxis: rare life‑threatening allergic response.

What precautions apply to Macrogol 4000?

When prescribing or dispensing Macrogol Aurovitas, consider the following safety measures. - Assess renal function: avoid use in patients with severe renal impairment. - Monitor electrolytes: especially during prolonged therapy. - Use with caution in the elderly: higher risk of dehydration. - Avoid in intestinal obstruction: may exacerbate blockage. - Review concomitant medications: potential for reduced absorption of other oral drugs. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

What does Macrogol 4000 interact with?

Macrogol 4000 can interact with other agents that affect gastrointestinal function or fluid balance.

Major Interactions (Avoid): - Other osmotic laxatives (e.g., lactulose): risk of severe diarrhea. - Mineral oil: may reduce laxative efficacy. - Diuretics: increased risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption of certain oral medications. - Oral antibiotics: potential changes in gut flora; monitor therapeutic response. - NSAIDs: increased likelihood of gastrointestinal irritation. - Oral supplements (e.g., iron): may have reduced absorption due to altered transit time.

Frequently asked questions

What is Macrogol Aurovitas used for?+
Macrogol Aurovitas contains macrogol 4000, an osmotic laxative that is used to relieve constipation, manage chronic idiopathic constipation, and to prepare the bowel for procedures such as colonoscopy by clearing intestinal contents.
How does macrogol 4000 work?+
Macrogol 4000 is a high‑molecular‑weight polyethylene glycol that remains largely unabsorbed in the gut. It draws water into the intestinal lumen by osmotic pressure, increasing stool water content, softening the stool, and stimulating peristalsis to promote bowel movements.
What is the usual dose of Macrogol Aurovitas?+
The dose of Macrogol Aurovitas is determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. The prescriber will provide specific instructions on the amount to dissolve and the frequency of administration.
Is Macrogol Aurovitas safe during pregnancy or breastfeeding?+
Safety data for macrogol 4000 in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks and consider alternative treatments if appropriate. Women who are pregnant or breastfeeding should discuss use with their physician.
How do I order Macrogol Aurovitas from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Macrogol Aurovitas compare with other laxatives?+
Compared with stimulant laxatives, macrogol 4000 works by osmotic water retention rather than stimulating intestinal nerves, resulting in a gentler, more physiologic bowel movement. It is often preferred for long‑term use because it has a lower risk of electrolyte imbalance and habit‑forming effects.
What are the storage and handling requirements for Macrogol Aurovitas?+
Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Macrogol Aurovitas administered?+
Macrogol Aurovitas is supplied as an oral powder that is dissolved in water or another clear fluid according to the prescriber’s instructions. The solution is then ingested, typically once daily, unless otherwise directed by a healthcare professional.
What are the most serious risks associated with Macrogol Aurovitas?+
Serious risks, though rare, include severe electrolyte disturbances, dehydration, allergic reactions such as rash or anaphylaxis, and significant abdominal pain or rectal bleeding. Patients should seek immediate medical attention if any of these symptoms occur.
Who should not use Macrogol Aurovitas?+
Macrogol Aurovitas should be avoided in patients with known hypersensitivity to macrogol or polyethylene glycol, in those with intestinal obstruction, severe renal impairment, or in individuals for whom an osmotic laxative is contraindicated. Clinical judgment is required for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Macrogol 4000
Route
Oral Use
Manufacturer
Aurovitas Spain,s.A.U.
Origin
EU

Related products

Casenjunior

Casenjunior

Macrogol 4000

Casen Recordati, S.L.
EU
Casenlax

Casenlax

Macrogol 4000

Casen Recordati, S.L.
EU
Casenlax

Casenlax

Macrogol 4000

Casen Recordati, S.L.
EU
Casenlax

Casenlax

Macrogol 4000

Casen Recordati, S.L.
EU